Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.95 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.74 |
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.74 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.74 |
| ▸ | FAAH | O00519 | 3/20 | 0.69 |
| ▸ | PPARG | P37231 | 3/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.68 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.68 |
| ▸ | FABP4 | P15090 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | CASP1 | P29466 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1480333 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL29926444 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL8728913 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL1479341 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL7718095 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL29926968 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL29926582 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL1480331 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL1479340 | 1.00 | OXER1 (0.95) | OXER1LTB4R2MAPTALDH1A1ALOX5 | |
| SCHEMBL16670813 | 0.97 | OXER1 (1.00) | OXER1LTB4R2MAPTALDH1A1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704797-A1 | OXYLIPINS IN THE TREATMENT OF SEBORRHEA | Pierre Fabre Dermo-Cosmétique (FR) | 2026-03-11 | — | — | EP | claimed |
| EP-4687496-A1 | COMPOSITION COMPRISING OXYLIPINS PRESENT IN HUMAN MILK DERIVED SMALL EXTRACELLULAR VESICLES AND ITS USE IN THE PREVENTION AND TREATMENT OF INTESTINAL DISEASES | Fundación Para la Investigación del Hospital Universitario y Politécnico La Fe de la Comunidad Valenciana (ES) | 2026-02-11 | — | — | EP | claimed |
| US-20250216407-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. | 2025-07-03 | — | — | US | claimed |
| CN-119069037-B | Detection method of heart failure detection biomarker based on oxidized lipid derivatization and machine learning model | 中国中医科学院医学实验中心 | 2025-02-14 | — | — | CN | claimed |
| EP-4468884-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-12-04 | — | — | EP | claimed |
| CN-119069037-A | Detection method of heart failure detection biomarker based on oxidized lipid derivatization and machine learning model | 中国中医科学院医学实验中心 | 2024-12-03 | — | — | CN | claimed |
| WO-2024227714-A1 | OXYLIPINS IN THE TREATMENT OF SEBORRHEA | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2024-11-07 | — | — | WO | claimed |
| WO-2024200855-A1 | COMPOSITION COMPRISING OXYLIPINS PRESENT IN HUMAN MILK DERIVED SMALL EXTRACELLULAR VESICLES AND ITS USE IN THE PREVENTION AND TREATMENT OF INTESTINAL DISEASES | FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO Y POLITECNICO LA FE DE LA COMUNIDAD VALENCIANA (ES) | 2024-10-03 | — | — | WO | claimed |
| EP-4437858-A1 | COMPOSITION COMPRISING OXYLIPINS PRESENT IN HUMAN MILK DERIVED SMALL EXTRACELLULAR VESICLES AND ITS USE IN THE PREVENTION AND TREATMENT OF INTESTINAL DISEASES | Fundación Para la Investigación del Hospital Universitario y Politécnico La Fe de la Comunidad Valenciana (ES) | 2024-10-02 | — | — | EP | claimed |
| CN-118714935-A | Lymphoreleased fatty acid compositions and their use for lymphatic incorporation and systemic disease treatment | 阿马里纳药物爱尔兰有限公司 | 2024-09-27 | — | — | CN | claimed |
| EP-4329742-A1 | COMPOSITIONS COMPRISING EPA AND METHODS OF USING THE SAME FOR TREATING AND/OR PREVENTING ENDOTHELIAL DYSFUNCTION IN A SUBJECT | Amarin Pharmaceuticals Ireland Limited (IE) | 2024-03-06 | — | — | EP | claimed |
| WO-2023192314-A1 | LIVER DISEASE TREATMENT AND ASSESSMENT USING OXYLIPINS | INIPHARM, INC. (US) | 2023-10-05 | — | — | WO | claimed |
| US-20230284643-A1 | MILK PRODUCT COMPOSITIONS | BIOMILQ INC (US) | 2023-09-14 | — | — | US | claimed |
| WO-2023146984-A1 | LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2023-08-03 | — | — | WO | claimed |
| WO-2023083380-A1 | METHOD FOR PREDICTING PROGNOSIS OF PATIENT WITH HEART FAILURE WITH ARACHIDONIC ACID METABOLOME DATA IN SERUM | 北京市心肺血管疾病研究所 | 2023-05-19 | — | — | WO | claimed |
| EP-4157990-A1 | MILK PRODUCT COMPOSITIONS | Biomilq, Inc. (US) | 2023-04-05 | — | — | EP | claimed |
| US-20230043035-A1 | AGAROPHYTON CHILENSIS EXTRACT, RICH IN FREE FATTY ACIDS, AS A NUTRACEUTICAL OR NUTRITIONAL SUPPLEMENT, SUITABLE FOR MODULATING PPAR# ACTIVITY | UNIVERSIDAD ANDRES BELLO (CL) | 2023-02-09 | — | — | US | claimed |
| CN-115698252-A | Dairy product composition | 生物乳业公司 | 2023-02-03 | — | — | CN | claimed |
| WO-2022232633-A1 | COMPOSITIONS COMPRISING EPA AND METHODS OF USING THE SAME FOR TREATING AND/OR PREVENTING ENDOTHELIAL DYSFUNCTION IN A SUBJECT | AMARIN PHARMACEUTICALS IRELAND LIMITED (IE) | 2022-11-03 | — | — | WO | claimed |
| CN-114034851-A | Method for predicting prognosis of heart failure patient by using arachidonic acid metabolome data in serum | 北京市心肺血管疾病研究所 | 2022-02-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043035-A1 | AGAROPHYTON CHILENSIS EXTRACT, RICH IN FREE FATTY ACIDS, AS A NUTRACEUTICAL OR NUTRITIONAL SUPPLEMENT, SUITABLE FOR MODULATING PPAR# ACTIVITY | PPARG, FFAR1, PPARA | OXER1 103/4885LTB4R2 1024/4885MAPT 2540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.